Published in Regenerative Therapy (Vol. 30, Dec 2025) A study in Regenerative Therapy shows that adipose-derived stem cells (ADSCs)...

Published on LinkedIn via Spencer Knight Jan Janisch-Hanzlik, 49, became the first person in the world to receive allogeneic CAR‑T...

Published on LinkedIn via Spencer Knight SERB Pharmaceuticals will acquire Y-mAbs Therapeutics for $412 million, marking a strategic...

Published on OncoDaily via Hung Trinh In a first‑in‑human trial led by UCLA, researchers demonstrated that hematopoietic stem cells...

Published by Cytotherapy via LinkedIn A new paper describes a fully integrated platform that automates three core CAR‑T manufacturing...

Published on LinkedIn via Spencer Knight In a groundbreaking study by Karolinska Institutet, ten patients born deaf due to a mutation in...

Published on LinkedIn via Spencer Knight The FDA has granted two approvals within 24 hours. Novartis’s Leqvio (inclisiran), a...

Published in Alliance for Regenerative Medicine (April 2025 Preview) A new whitepaper from the Alliance for Regenerative Medicine...

Published on Mass General Brigham After years of debilitating pain from sickle cell disease, Allan Byamukama became one of the first...

Published on LinkedIn via Spencer Knight AbbVie has secured worldwide rights to ISB 2001, a first-in-class trispecific antibody developed...

Published on LinkedIn via Spencer Knight GSK has entered a $12 billion licensing deal with China’s Hengrui Pharma, paying $500 million...

Published on Autolus Therapeutics News Releases Autolus’s CAR‑T therapy, AUCATZYL (obecabtagene autoleucel), has received marketing...

Published on Stanford Medicine News Stanford researchers have successfully used an antibody, briquilimab, to prepare children with...

A new paper in Cytotherapy describes an integrated platform that may significantly accelerate how CAR-T cells are produced. Researchers...

Published on LinkedIn via Laurie Adami Laurie Adami shared her 7-year remission milestone after receiving Yescarta CAR‑T therapy in a...

Published on NIH Research Matters NIH-funded researchers led by Capstan Therapeutics and the University of Pennsylvania have devised a...

Published on Fierce Biotech A recent Jefferies report reveals that in Q1 2025, China-based biotechs accounted for 32 percent of global...

Published in Journal of Translational Medicine A recent study explores how solid tumors alter CAR‑T cell lipid metabolism, affecting...

Published on LinkedIn via Spencer Knight AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics to deepen its investment...

Published on LinkedIn via Spencer Knight The FDA has updated CAR-T therapy regulations for BMS’ Abecma and Breyanzi, removing REMS...